🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Radiolabeled monoclonal antibodies can locate cancer cells and e...
Status
Unknown
Location
Garden State Cancer Center
Start Date
1997-06
Trial ID
NCT00004086
The investigators propose a randomized phase 2 study evaluating 90Y-epratuz...
Status
Withdrawn
Location
CHU de Clermont-Ferrand
Start Date
TBD
Trial ID
NCT02844530
Treatments Being Tested
The goal of this study is to evaluate a new approach to immunotherapy in NH...
Status
Withdrawn
Location
Helen F. Graham Cancer Center
Start Date
2010-05
Trial ID
NCT01101581
Treatments Being Tested
Determination of the maximum tolerated dose (MTD) of fractionated RIT with ...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT02577094
A Phase I/II clinical trial using a fractionated dosing regimen of 90Y-epra...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2010-10
Trial ID
NCT01147393
Treatments Being Tested
The purpose of this study is to determine whether fractionated RIT with Epr...
Status
Unknown
Location
CHU Nantes
Start Date
2010-11
Trial ID
NCT01354457
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate cancer cells and d...
Status
Completed
Location
Garden State Cancer Center
Start Date
1998-02
Trial ID
NCT00004107